Phathom Pharmaceuticals Inc. has filed an initial statement of beneficial ownership (Form 3) with the SEC. The filing lists Sanjeev Narula as the beneficial owner, serving as the company's Chief Financial and Business Officer. The full filing can be accessed through the link below.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Phathom Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-233666), on October 07, 2025, and is solely responsible for the information contained therein.